Trial Profile
Prospective Pharmacokinetic and Pharmacogenetic Analysis of Advagraf After Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacogenomic; Pharmacokinetics
- Acronyms AADAPT
- 17 Dec 2012 Planned End Date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 01 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 20 Sep 2011 New trial record